NCT07662317 Construction of a Prospective Cohort Database for the Perioperative Period of Cardiac Surgery
| NCT ID | NCT07662317 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Second Affiliated Hospital, School of Medicine, Zhejiang University |
| Condition | Valve Heart Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 10,000 participants |
| Start Date | 2026-06-25 |
| Primary Completion | 2031-05-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 10,000 participants in total. It began in 2026-06-25 with a primary completion date of 2031-05-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Cardiovascular disease (CVD) is the leading cause of global morbidity and mortality, with its prevalence increasing significantly from 1990 to 2019. Establishing a comprehensive cardiac surgery database is crucial for exploring perioperative prognostic factors and improving clinical outcomes. This muti-center, prospective observational study aims to construct a prospective cohort database for perioperative cardiac surgery. We plan to enroll adult patients who undergo cardiac surgery with cardiopulmonary bypass at the Second Affiliated Hospital of Zhejiang University and other hospitals from May 1, 2026 to December 31, 2031. Multi-dimensional perioperative data, including laboratory tests, hemodynamics, intraoperative echocardiography, and perioperative medications, will be collected and integrated, along with epidemiological data, clinical diagnosis and treatment information, multimodal data, and follow-up outcomes. An interconnected big data sharing platform will also be built. This database will provide a valuable resource for multi-level researches such as perioperative risk assessment, individualized prevention, precise diagnosis and treatment, and therapeutic efficacy monitoring. It will also help optimize surgical and perioperative management, improve the quality of cardiac surgery, and provide evidence for the refinement of China's healthcare system, ultimately enhancing perioperative safety and rehabilitation efficiency of patients.
Eligibility Criteria
Inclusion Criteria: * Patients undergoing cardiac surgery from May 1, 2026 to December 31, 2031 Exclusion Criteria: * Refusal to provide informed consent
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07662317 clinical trial?
This trial is open to participants of all sexes, studying Valve Heart Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07662317 currently recruiting?
Yes, NCT07662317 is actively recruiting participants. Contact the research team at zryanmin@zju.edu.cn for enrollment information.
Where is the NCT07662317 trial being conducted?
This trial is being conducted at Hangzhou, China.
Who is sponsoring the NCT07662317 clinical trial?
NCT07662317 is sponsored by Second Affiliated Hospital, School of Medicine, Zhejiang University. The trial plans to enroll 10,000 participants.